CI Private Wealth »

Gt Biopharma shares owned by CI Private Wealth

Quarter-by-quarter ownership of Gt Biopharma (GTBP) shares owned by CI Private Wealth from 13F filings

Historical chart of CI Private Wealth investment in Gt Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Gt Biopharma held by CI Private Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gt Biopharma by CI Private Wealth

Quarter filed Position value Share count Share price at filing
2026-06-30 $9.8k 20k 0.49

More positions owned by CI Private Wealth

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
Costco Wholesale Corporation (COST)

View all positions for CI Private Wealth

Top funds holding Gt Biopharma

Vanguard Capital Management
Geode Capital Management
Vanguard Fiduciary Trust
Hrt Financial
Everhart Financial Group
SRS Capital Advisors
Opal Wealth Advisors
Northern Trust
49 Wealth Management
Alongside
Cetera Investment Advisers
SeaCrest Wealth Management
Kitching Partners
Pnc Financial Services
Advisor Group Holdings

View all funds holding Gt Biopharma